William T. (Taylor) Kimberly, MD, PhD
Associate Director, Neuroscience Intensive Care Unit
- Department of Neurology
- Critical Care Center
- Neuroscience Intensive Care Unit
- Vascular Center
- Clinical Interests
- Neurocritical Care
- Subarachnoid hemorrhage
- Boston: Massachusetts General Hospital
- Medical Education
- MD, PhD, Harvard Medical School
- Residency, Brigham and Women's Hospital
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Neurology, American Board of Psychiatry and Neurology
- Accepting New Patients
- Insurances Accepted
- Aetna Health Inc.
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
Cigna (PAL #'s)
Fallon Community HealthCare
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - ACD
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
Medicare - ACD
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
OSW - Connecticut
OSW - Maine
OSW - New Hampshire
Private Health Care Systems (PHCS)
Senior Whole Health
Tufts Health Plan
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
BiographyW. Taylor Kimberly, MD PhD is a stroke and critical care neurologist in the Department of Neurology. He serves as the Associate Director of the MGH Neuroscience Intensive Care Unit and is an Assistant Professor of Neurology at Harvard Medical School.
Clinically, he cares for patients in the Neuroscience intensive care unit as part of an integrated and multi-disciplinary team model with Neurosurgery and Neuroendovascular specialists. He works on several hospital-based and national committees that focus on clinical guideline development and quality improvement.
Dr. Kimberly's research group is located in the Center for Human Genetic Research, and studies blood-based and neuroimaging biomarkers of subarachnoid hemorrhage, stroke and cerebral edema. Through the use of metabolomics and neuroimaging, the goal is to identify novel therapeutic targets for acute brain injury. Dr. Kimberly also co-leads a phase II multi-site, randomized, placebo-controlled trial that is evaluating the safety and efficacy of a novel compound in preventing brain edema.
View my most recent publications at PubMed
Wolfe MS et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and g-secretase activity. Nature
, 398:513-517 (1999).
Kimberly WT et al. g-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1 and pen-2. Proc. Natl. Acad. Sci. U.S.A.
, 100:6382-6387 (2003).
Singhal AS et al. Case Records of the Massachusetts General Hospital. A 36-year-old woman with headache, hypertension, and seizure 2 weeks post-partum. New Engl. J. Med.
, 360:1126-1137 (2009).
Kimberly WT et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology, 72:1230-1235 (2009).
Kimberly WT et al. Lower hemoglobin correlates with larger stroke volumes in acute ischemic stroke. Cerebrovasc. Dis. Extra, 1:44-53 (2011).
O'Connor SG et al. Process improvement methods increase the efficiency, accuracy and utility of a neurocritical care research repository. Neurocrit. Care, 17:90-96 (2012).
Kimberly et al. Sex differences and hemoglobin levels in relation to stroke outcomes. Neurology, 80: in press (2013).
Massachusetts General Hospital investigators collaborate with clinical staff to generate new knowledge and discuss innovations at the First Annual Critical Care Research Retreat.
Neurosciences Intensive Care Unit
55 Fruit Street
Boston, MA 02114-2696
15 Parkman Street
Boston, MA 02114-3117
Phone 2: 617-726-8071
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.